A detailed history of Fin Trust Capital Advisors, LLC transactions in Viatris Inc stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 752 shares of VTRS stock, worth $9,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
752
Previous 620 21.29%
Holding current value
$9,324
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$10.32 - $12.13 $1,362 - $1,601
132 Added 21.29%
752 $8,000
Q2 2024

Jul 24, 2024

SELL
$10.05 - $12.02 $3,316 - $3,966
-330 Reduced 34.74%
620 $6,000
Q1 2024

May 02, 2024

SELL
$11.27 - $13.53 $157 - $189
-14 Reduced 1.45%
950 $11,000
Q4 2023

Feb 13, 2024

SELL
$8.77 - $10.85 $324 - $401
-37 Reduced 3.7%
964 $10,000
Q3 2023

Oct 24, 2023

SELL
$9.59 - $11.35 $1,726 - $2,043
-180 Reduced 15.24%
1,001 $9,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $270 - $358
-31 Reduced 2.56%
1,181 $13,000
Q3 2022

Oct 20, 2022

SELL
$8.48 - $11.13 $2,247 - $2,949
-265 Reduced 17.94%
1,212 $12,000
Q2 2022

Jul 26, 2022

SELL
$9.95 - $12.27 $13,800 - $17,018
-1,387 Reduced 48.43%
1,477 $14,000
Q1 2022

May 03, 2022

SELL
$9.81 - $15.4 $45,920 - $72,087
-4,681 Reduced 62.04%
2,864 $31,000
Q4 2021

Feb 14, 2022

SELL
$12.09 - $14.68 $9,877 - $11,993
-817 Reduced 9.77%
7,545 $102,000
Q3 2021

Nov 16, 2021

BUY
$13.25 - $15.13 $39,061 - $44,603
2,948 Added 54.45%
8,362 $113,000
Q2 2021

Aug 16, 2021

BUY
$12.97 - $16.15 $34,565 - $43,039
2,665 Added 96.94%
5,414 $77,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $6,577 - $8,973
-484 Reduced 14.97%
2,749 $38,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $46,231 - $60,586
3,233 New
3,233 $61,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.